Rchr
J-GLOBAL ID：200901069538310490
Update date: Apr. 17, 2024
Tanaka Toshio
タナカ トシオ | Tanaka Toshio
Affiliation and department：
Research field (1)：
Allergies and connective tissue disease
Research keywords (3)：
アレルギー性疾患
, 免疫性疾患
, Immunological and allergic diseases
Research theme for competitive and other funds (2)：
- 2005 - 2006 I型アレルギーの発症予防に関する研究
- 2005 - 2006 Study on prevention of allergic diseases
MISC (358)：
-
Atsushi Ogata, Atsuyoshi Morishima, Toru Hirano, Yoshihiro Hishitani, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. ANNALS OF THE RHEUMATIC DISEASES. 2011. 70. 6. 1164-1165
-
Atsushi Ogata, Atsuyoshi Morishima, Toru Hirano, Yoshihiro Hishitani, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab. ANNALS OF THE RHEUMATIC DISEASES. 2011. 70. 6. 1164-1165
-
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab. Mod Rheumatol. 2011. 2011 Jan 15. [Epub ahead of print]
-
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis. Mod Rheumatol. 2011. 2011 Feb 9. [Epub ahead of print]
-
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. FEBS Letters. 2011. 2011 March 22. [Epub ahead of print]
ｍore...
Books (3)：
-
Is an appropriate intake of flavonoids a prophylactic means or complementary and alternative medicine for allegoric diseases?
Recent Research Development in Allergy & Clinical Immunology 2004
-
Interleukin 6. Cytokine regulation of immunoglobulin synthesis and class switching
John Wiley & Sons. Ltd. England 1996
-
IL-2, IL-4, IL-6, IL-10, IFN-r, their receptors, modulation of their actions and role on allergic responses
Immunopharmacology of Allergic Diseases edited by Townley R. G. 1996
Works (44)：
-
難治性疾患克服研究事業 成人型分類不能型免疫不全症の実態把握、亜群特定に基づく診断基準策定及び病態解明に関する研究
2009 -
-
平成21年度保健医療分野における基礎研究推進事業 “未だ有効な治療法がない免疫、腫瘍性疾患に対する抗IL-6受容体抗体による新規治療法の開発
2009 -
-
CNTO184(Golimumab)の関節リウマチ患者を対象とした単剤投与試験
2008 -
-
平成20年度科学研究費補助金 基盤研究(C)“アレルギー疾患に対するフラボノイドによる食事療法の開発”
2008 -
-
平成20年度保健医療分野における基礎研究推進事業 “未だ有効な治療法がない免疫、腫瘍性疾患に対する抗IL-6受容体抗体による新規治療法の開発
2008 -
ｍore...
Education (4)：
- - 1989 Osaka University
- - 1989 Osaka University Graduate School, Division of Medicine
- - 1983 Osaka University Faculty of Medicine
- - 1983 Osaka University Faculty of Medicine
Professional career (1)：
Work history (2)：
- 1989 - 1991 米国国立衛生研究所感染アレルギー部門 外国研究生
- 1989 - 1991 National Institutes of Health(USA)Research fellow
Association Membership(s) (5)：
リウマチ学会
, 米国免疫学会
, アレルギー学会
, 免疫学会
, 内科学会
